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Editorial on the Research Topic
Purinergic Signaling in Health and Disease
Adenosine 5′-triphosphate (ATP) is one of the most abundant molecules in living cells
serving as universal energy “currency.” After slow acceptance of the concept of the release
and extracellular action of ATP and its breakdown products, ADP and adenosine, purinergic
signaling has been recognized as a widespread mechanism for cell-to-cell communication in
living organisms. Additionally, the contribution of pyrimidine nucleotides (such as UTP and
UDP) and sugar-nucleotides (i.e., UDP-glucose and UDP-galactose) have been more recently
discovered. Purinergic signaling plays major physiological roles in mammalian central nervous
system (CNS) such as neurotransmission, neuromodulation, communication in glial network, and
between neurons and glia. The high number of signaling molecules provides the versatile basis
for complex purinergic signaling through the activation of several families of receptors. G-protein
coupled P1 receptors for adenosine, ionotropic P2X receptors for ATP and G-protein coupled P2Y
receptors for ATP and other nucleotides are abundant and widely distributed in central neurons
at pre-and post-synapse and in glial cells. Dysregulations of purinergic signals are associated with
major CNS disorders including chronic pain, brain trauma ischemia, epilepsy, neurodegenerative
diseases such as Alzheimer’s disease (AD) or Amyotrophic lateral sclerosis (ALS) associated
with neuro-inflammation as well as neuropsychiatric diseases, including depression, anxiety,
and schizophrenia.
In this Research Topic we have brought together 22 articles written by 145 authors containing 7
reviews, 1 hypothesis and theory, 1 brief research report, and 13 original research articles. Review
articles present several up-to-date aspects of the biology of purinergic signaling in the nervous
system, such as in the vertebrate olfactory system (Rotermund et al.) or in the preBötzinger
Complex (Reklow et al.). Other reviews focus on the structure-function of P2X receptors (Peverini
et al.) and on the function of adenosine receptor agonists, guanine-based purines and vesicular
nucleotide transporter in health and disease emphasizing their therapeutic potential in neurological
disorders (Jacobson et al.; Tasca et al.; Miras-Portugal et al.). The function of P2X7 receptor and its
regulation by its wide interactome is also reviewed (Kanellopoulos and Delarasse; Kopp et al.). In
addition, the diversity of P2X7 function is underlined in an original research article showing the
role of P2X7 in the regulation of the whole-body energy metabolism (Giacovazzo et al.). P2X7
receptor distribution was also examined in a ß-amyloid mouse model and revealed its microglial
upregulation at advanced and late stages of the disease (Martínez-Frailes et al.). The other original
research papers are covering important aspects of purinergic receptor function and regulation in
the CNS. Several papers focus on the role of adenosine A2A receptors expressed in distinct brain
region such as the prefrontal cortex (PFC), the hippocampus and the striatum and their role of
associated behavior. By a selective downregulation of A2AR selectively in prelimbic medial PFC the
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authors revealed the role of A2A in physiological behaviors
such as decision making (Leffa et al.). A distinct strategy was
used to knockdown A2AR in two striatal regions, the nucleus
accumbens and the dorsal medium striatum and results show
that downregulation of A2A increased attention and motivation
(Zhou et al.). Long lasting blockade of A2A receptor activity by a
selective antagonist in a ß-amyloid mouse model of AD improves
memory deficit and reduces cortical amyloid load consistent
with a beneficial role of A2AR blockade for AD (Faivre et al.)
and with the idea that consumption of caffeine reduces the risk
of developing the pathology. However, an article reveals that
caffeine consumption during pregnancy may have opposite effect
representing a risk-factor for early appearance of AD symptoms
in the off-springs of a transgenic mouse model of tauopathy
(Zappettini et al.). Several articles focus on P2X4 receptors
describing new structural features based on the identification
of a selective allosteric inhibitory site (Ase et al.) or novel
specific monoclonal antibodies and nanobodies recognizing
specifically P2X4 receptors in its native conformation (Bergmann
et al.), as well as a role of intracellular P2X4 in lysosomal
exocytosis that may be implicated in HIV associated neuropathy
(Datta et al.). In the striatum, pharmacological manipulations
of P2X4 and dopamine receptors show the role of the
interplay between purinergic and dopaminergic signaling in
the regulation of sensorimotor information processing (Khoja
et al.). Spatio-temporal expression profile of P2X subunits during
embryogenesis in Xenopus reveal that several P2X receptors may
have distinct role during development including neurogenesis
(Blanchard et al.). Neuromodulation of cortical excitatory or
inhibitory synapses by P2X receptors activated by ATP released
from neurons as well as from astrocytes in the neocortex is altered
during aging, suggesting that alteration of ATP signaling may
contribute to age-dependent impairment of synaptic activities,
but can be partially rescued by positive experience, such
as environmental enrichment (Lalo et al.). Fasting/refeeding
conditions in rats show that increased expression of P2X2
is associated to increase neuronal activity in the supraoptic
nucleus of the hypothalamus and arginine vasopressin release
(Ivetic et al.). Finally, purinergic profiling of blood T cells of
patients with migraine suggests the involvement of purinergic
signaling in this disorder with increase of ATP-dependent
pro-inflammatory and reduction of adenosine-mediated anti-
inflammatory mechanism (Nurkhametova et al.).
Overall, this Research Topic provides an up-to-date
overview of the diversity of the purinergic signaling
function in the CNS and provides new insights on the
importance of their engagement in physiological and
pathological conditions.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct and intellectual
contribution to the work, and approved it for publication.
ACKNOWLEDGMENTS
We thank all authors for their contribution to this Research Topic
and we would like also to acknowledge the work of reviewers
whose constructive comments contributed to improve the quality
of the articles.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Boué-Grabot, Blum and Ceruti. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 February 2020 | Volume 14 | Article 15
